Maxacalcitol
Specifications
103909-75-7CAS Number
686-295-2EC Number
trans-(1R,3S,5Z)-5-[(2E)-2-[(1S,3aS,7aS)-1-[(1S)-1-(3-hydroxy-3-methylbutoxy)ethyl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidenecyclohexane-1,3-diolIUPAC Name
C26H42O4Chemical Formula
418.6 g/molMolecular Weight
Maxacalcitol; 22-Oxacalcitriol; 103909-75-7; Prezios; Oxarol; maxacalcitriol; 22-oxa-calcitriol; Sch 209579; Sch-209579; 22-Oxa-1,25-dihydroxyvitamin D3; DTXSID4048648; N2UJM5NBF6; SCH209579; (+)-(5Z,7E,20S)-20-(3-Hydroxy-3-methylbutoxy)-9,10-secopregna-5,7,10(19)-triene-1alpha,3beta-diol; 1,3-Cyclohexanediol, 4-methylene-5-((2E)-((1S,3aS,7aS)-octahydro-1-((1S)-1-(3-hydroxy-3-methylbutoxy)ethyl)-7a-methyl-4H-inden-4-ylidene)ethylidene)-, (1R,3S,5Z)-; 1,25-Dihydroxy-22-oxavitamin D3; (1R,3S,5Z)-5-[(2E)-2-[(1S,3aS,7aS)-1-[(1S)-1-(3-hydroxy-3-methylbutoxy)ethyl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidenecyclohexane-1,3-diol; DTXCID1028574; maxacalcitolum; RefChem:810671; (1R,3S,5Z)-5-((2E)-2-((1S,3aS,7aS)-1-((1S)-1-(3-hydroxy-3-methylbutoxy)ethyl)-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene)ethylidene)-4-methylidenecyclohexane-1,3-diol; 1alpha,25-Dihydroxy-22-oxavitamin D3; Maxacalcitol [USAN]; oxacalcitriol; Maxacalcitrol; (5Z,7E)-(1S,3R)-22-oxa-9,10-seco-5,7,10(19)-cholestatriene-1,3,25-triol; (1s,3r,5z,7e,14beta,17alpha,20s)-20-(3-Hydroxy-3-Methylbutoxy)-9,10-Secopregna-5,7,10-Triene-1,3-Diol; Prezios (TN); UNII-N2UJM5NBF6; 22-Oxa-1,25(OH)2D3; Maxacalcitol [USAN:INN]; MC 1275; 22-Oxacalcitrol; (1R,3S,Z)-5-(2-((1S,3aS,7aS,E)-1-((S)-1-(3-hydroxy-3-methylbutoxy)ethyl)-7a-methyloctahydro-4H-inden-4-ylidene)ethylidene)-4-methylenecyclohexane-1,3-diol; Oxarol (TN); MAXACALCITOL [MI]; MAXACALCITOL [INN]; MAXACALCITOL [JAN]; SCHEMBL2745; MAXACALCITOL [MART.]; MAXACALCITOL [WHO-DD]; CHEMBL333950; GTPL2784; Maxacalcitol (JAN/USAN/INN); CHEBI:31801; 22-oxa-1alpha,25(OH)2D3; (+)-(5Z,7E)-(1S,3R,20S)-20-(3-Hydroxy-3-methylbutyloxy)-9,10-secopregna-5,7,10(19)-triene-1,3-diol; EX-A4433; Maxacalcitol; (1R,3S,Z)-5-(2-((1S,3aS,7aS,E)-1-((S)-1-(3-hydroxy-3-methylbutoxy)ethyl)-7a-methyloctahydro-4H-inden-4-ylidene)ethylidene)-4-methylenecyclohexane-1,3-diol; 1a,25-Dihydroxy-22-oxavitamin D3; BDBM50124417; LMST03020060; AKOS005145563; AC-8888; CS-0392; MC-1275; (1R,3S,5Z)-4-Methylene-5-[(2E)-2-[(1S,3aS,7aS)-octahydro-1-[(1S)-1-(3-hydroxy-3-methylbutoxy)ethyl]-7a-methyl-4H-inden-4-ylidene]ethylidene]-1,3-cyclohexanediol; (1R,3S,5Z)-5-{2-[(1S,3aS,4E,7aS)-1-[(1S)-1-(3-hydroxy-3-methylbutoxy)ethyl]-7a-methyl-octahydro-1H-inden-4-ylidene]ethylidene}-4-methylidenecyclohexane-1,3-diol; (1S-(1alpha(R*),3abeta,4E(1S*,3R*,5Z),7aalpha))-4-Methylene-5-(2-(octahydro-1-(1-(3-hydroxy-3-methylbutoxy)ethyl)-7a-methyl-4H-inden-4-ylidiene)ethylidene-1,3-cyclohexanediol; 1,3-Cyclohexanediol, 4-methylene-5-(2-(octahydro-1-(1-(3-hydroxy-3-methylbutoxy)ethyl)-7a-methyl-4H-inden-4-ylidene)ethylidene)-, (1S-(1alpha(R*),3abeta,4E(1S*,3R*,5Z),7aalpha))-; FM158459; HY-32339; 1alpha,25-dihydroxy-22-oxacholecalciferol; 22-OXA-1a,25-DIHYDROXYCHOLECALCIFEROL; D01098; Q27083635; (5Z,7E)-9,10-SECO-22-OXACHOLESTA-5,7,10(19)-TRIENE-1a,3?,25-TRIOL; 1alpha,25-dihydroxy-22-oxavitamin D3 / 1alpha,25-dihydroxy-22-oxacholecalciferol; (+)-(5Z,7E,20S)-20-(3-HYDROXY-3-METHYLBUTOXY)-9,10-SECOPREGNA-5,7,10(19)-TRIENE-1.ALPHA.,3.BETA.-DIOL; (1S,3R,5Z,7E,20S)-20-(3-Hydroxy-3-methylbutoxy)-9,10-secopregna-5,7,10-triene-1,3-diol; (1S-(1.ALPHA.(R*),3A.BETA.,4E(1S*,3R*,5Z),7A.ALPHA.))-4-METHYLENE-5-(2-(OCTAHYDRO-1-(1-(3-HYDROXY-3-METHYLBUTOXY)ETHYL)-7A-METHYL-4H-INDEN-4-YLIDIENE)ETHYLIDENE-1,3-CYCLOHEXANEDIOL; 1,3-CYCLOHEXANEDIOL,4-METHYLENE-5-[(2E)-2-[(1S,3AS,7AS)-OCTAHYDRO-1-[(1S)-1-(3-HYDROXY-3-METHYLBUTOXY)ETHYL]-7A-METHYL-4H-INDEN-4-YLIDENE]ETHYLIDENE]-,(1R,3S,5Z)-Synonyms
